But the true catastrophe had yet to break.
Six weeks later, I received an urgent review request from the FDA’s Center for Devices and Radiological Health. Vance Biomedical had pushed an expedited Investigational Device Exemption (IDE) to begin human clinical trials for a wound-healing film based on my research. To secure approval, someone at the company had submitted a technical dossier that I recognized instantly.
It was mine. And it was horribly incomplete.
That specific folder had been explicitly tagged in my personal archives with three bold words: DRAFT. UNVALIDATED.
It was missing eight weeks of crucial safety data because early animal testing had revealed a delayed, severe inflammatory response in a subset of subjects.
Chloe had pulled the draft folder from the company’s legacy server after I left and presented it to the regulatory team as a final, validated report.
The human clinical trial had been running for eleven weeks. Three patients had already experienced severe adverse inflammatory reactions—the exact complication my incomplete data warned against.
The FDA halted the trial immediately and launched a formal investigation into regulatory fraud.
One morning, my program director walked into my office. “Evelyn, federal regulators are holding a formal evidentiary hearing. Vance Biomedical’s submitted files are being cross-referenced with your original research. They need you present.”
A knot tightened in my stomach. Not because of Julian, and not because of Chloe.
But because three innocent patients had been harmed by my family’s reckless arrogance.
Two days later, I walked into a federal conference room filled with regulatory officials, corporate attorneys, and executive representatives.
Sitting in the fourth row was Julian. Beside him sat Chloe.
For the first time since the night of the rose petals, neither of them looked confident.
I mounted my drive and brought up the projection screen.
The first slide displayed the original file metadata, my cryptographic digital signature, and the prominent red warning banner that Chloe had deleted before submitting the files to the FDA.
I watched my father’s face drain of all color.
Because the very next slide wouldn’t just prove the data belonged to me. It would reveal the exact user account that had tampered with the file.